TickerFacts.

Galmed Pharmaceuticals Ltd. (EOCN): Operating Income

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Operating Income is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

-$30.21M
Year ended 2020-12-31
2017-12-31: -$12.36M2018-12-31: -$10.71M2019-12-31: -$22.38M2020-12-31: -$30.21M-$30.21M
2017-12-31 Operating Income (USD) 2020-12-31
Period endedOperating IncomeChange YoYSource filing
2020-12-31-$30.21Mn/m2021-03-18, From 2020-01-01
2019-12-31-$22.38Mn/m2021-03-18, From 2019-01-01
2018-12-31-$10.71Mn/m2021-03-18, From 2018-01-01
2017-12-31-$12.36Mn/a2020-03-12, From 2017-01-01